- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 18.07. | GeneDx Leads Russell 2000 This Year As It Shifts To More Comprehensive Genetic Testing | 2 | Benzinga.com | ||
| 17.07. | Expert Ratings For GeneDx Holdings | 1 | Benzinga.com | ||
| 11.07. | GeneDx Holdings Corp.: GeneDx to Report Second Quarter 2024 Financial Results on Tuesday, July 30, 2024 | 1 | GlobeNewswire (USA) | ||
| 26.06. | The Latest Analyst Ratings For GeneDx Holdings | 1 | Benzinga.com | ||
| 24.06. | GeneDx Holdings Corp. - 8-K, Current Report | 1 | SEC Filings | ||
| 10.06. | GeneDx Holdings Corp.: GeneDx Announces Collaboration with Epic Aura to Expand Access to Rapid Whole Genome Sequencing (rWGS) Services to Inform Diagnosis in Affected Pediatric and Neonatal Patients | 166 | GlobeNewswire (Europe) | -- New integration to streamline access for health systems and improve provider and patient journeys using Epic for electronic connections -- -- Increases commercial footprint and focus on accelerating... ► Artikel lesen | |
| 05.06. | GeneDx Holdings Corp.: GeneDx Announces Patient Access Program to Expand Access to Exome Testing for Pediatric Epilepsy Patients | 106 | GlobeNewswire (Europe) | STAMFORD, Conn., June 05, 2024 (GLOBE NEWSWIRE) -- GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced the first-of-its-kind patient access... ► Artikel lesen | |
| 22.05. | GeneDx Holdings Corp.: GeneDx to Participate in Upcoming Investor Conferences | 2 | GlobeNewswire (USA) | ||
| 16.05. | Hedge Fund and Insider Trading News: Michael Burry, Leon Cooperman, Ray Dalio, Stanley Druckenmiller, Millennium Management, Paulson & Co, Rokos Capital Management, Humacyte Inc (HUMA), GeneDx Holdings Corp. (WGS), and More | 8 | Insider Monkey | ||
| 30.04. | Pre-market Movers: Cyclacel Pharmaceuticals, Marin Software, GeneDx, Sensata Technologies, Lichen China | 1.043 | AFX News | INDIANAPOLIS (dpa-AFX) - The following are some of the stocks making big moves in Tuesday's pre-market trading (as of 08.05 A.M. ET).In the Green Cyclacel Pharmaceuticals, Inc. (CYCC) is up... ► Artikel lesen | |
| 30.04. | Why GeneDx Shares Are Trading Higher By 37%; Here Are 20 Stocks Moving Premarket | 4 | Benzinga.com | ||
| 30.04. | Earnings call: GeneDx reports 51% revenue surge, eyes profitability by 2025 | - | Investing.com | ||
| 29.04. | GeneDx Stock Climbs After Better-Than-Expected Q1 Results, Raises FY24 Guidance | 2 | Benzinga.com | ||
| 29.04. | GeneDx reports Q1 results | 1 | Seeking Alpha | ||
| 29.04. | GeneDx Holdings Corp. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 29.04. | GeneDx Holdings Corp.: GeneDx Reports First Quarter 2024 Financial Results and Business Highlights | 153 | GlobeNewswire (Europe) | Reported first quarter 2024 revenue from continuing operations1 of $61.5M with 96% year-over-year growth of exome and genome test revenue Expanded first quarter 2024 adjusted gross margins2 from... ► Artikel lesen | |
| 23.04. | GeneDx Holdings Corp.: GeneDx Announces Partnership with Komodo Health to Expand Access to World's Largest Rare Disease Dataset | 165 | GlobeNewswire (Europe) | STAMFORD, Conn., April 23, 2024 (GLOBE NEWSWIRE) -- GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced a strategic partnership with Komodo... ► Artikel lesen | |
| 04.04. | GeneDx Holdings Corp.: GeneDx to Report First Quarter 2024 Financial Results on Monday, April 29, 2024 | 2 | GlobeNewswire (USA) | ||
| 14.03. | GeneDx Holdings Corp.: GeneDx to Present Data at the 2024 American College of Medical Genetics (ACMG) Annual Meeting Demonstrating Clinical Superiority of its Exome, Paving the Way for the Future of Genomics | 1 | GlobeNewswire (USA) | ||
| 26.02. | GeneDx Holdings Corp.: GeneDx to Participate in 44th Annual Cowen Health Care Conference | 1 | GlobeNewswire (USA) |
Seite:
1 2 Weiter >>
37 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ECKERT & ZIEGLER | 43,360 | +2,12 % | Eckert&Ziegler-Aktie leicht im Minus (43,00 €) | Im deutschen Wertpapierhandel liegt das Wertpapier von Eckert&Ziegler derzeit im Minus. Zuletzt zahlten Investoren für die Aktie 43,00 Euro. Ein Wertverlust in Höhe von 1,54 Euro müssen derzeit die... ► Artikel lesen | |
| INTUITIVE SURGICAL | 407,00 | +0,12 % | Better Buy: Abbott Laboratories vs. Intuitive Surgical | ||
| ROKU | 54,18 | -0,39 % | Why Roku Stock Was Slipping This Week | ||
| BICO GROUP | 3,664 | -0,60 % | Schock-News für Bico Group Anleger vor dem Wochenende: So müssen Sie heute noch auf diese Sondermeldung reagieren! | ||
| ATOSSA THERAPEUTICS | 1,266 | -6,22 % | Atossa Therapeutics, Inc.: Atossa Therapeutics Completes Enrollment of 80mg Pharmacokinetic Run-In Cohort in Phase 2 EVANGELINE Clinical Trial Evaluating (Z)-Endoxifen as a Neoadjuvant Treatment for ER+ / HER2- Breast Cancer | SEATTLE, July 22, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) ("Atossa" or the "Company") today announced that the 12-patient 80mg pharmacokinetic (PK) run-in cohort of the Phase... ► Artikel lesen | |
| EVOFEM BIOSCIENCES | - | - | Lupin Divests U.S. Commercial Women's Health Specialty Business To Evofem Biosciences | NEW DELHI (dpa-AFX) - Pharma major Lupin Ltd. announced Monday that it has divested its U.S. Commercial Women's Health Specialty Business to Evofem Biosciences, Inc. (EVFM), a U.S. biopharmaceutical... ► Artikel lesen | |
| ASENSUS SURGICAL | 0,299 | -3,92 % | Asensus Surgical, Inc.: Asensus Surgical Receives FDA 510(k) Clearance for Senhance Surgical System in Urology | RESEARCH TRIANGLE PARK, N.C., July 23, 2024 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a global leader of innovative digital solutions for the operating room, today announced... ► Artikel lesen | |
| QUIDELORTHO | 35,200 | -0,56 % | S&P Dow Jones Indices: Avantor Set to Join S&P MidCap 400; QuidelOrtho & Schneider National to Join S&P SmallCap 600 | NEW YORK, July 23, 2024 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P MidCap 400 and S&P SmallCap 600:
Avantor Inc. (NYSE:AVTR) will replace QuidelOrtho Corp.... ► Artikel lesen | |
| TEMPEST THERAPEUTICS | 1,588 | +1,15 % | Aktien New York Ausblick: Weitere Tech-Rekorde - Nasdaq 100 mit 20 000 Punkten | NEW YORK (dpa-AFX) - Nach dem Feiertag zur Wochenmitte dürften die US-Aktienmärkte am Donnerstag gut behauptet eröffnen. Dabei sollten die Technologiewerte - allen voran die Halbleiterbranche - an... ► Artikel lesen | |
| VERU | 0,843 | -3,33 % | Veru Inc.: Veru Reports Fiscal 2024 Second Quarter Financial Results and Progress of its Enobosarm High Quality Weight Loss Clinical Program | --Phase 2b clinical study of enobosarm in combination with semaglutide (Wegovy®*) for high quality weight loss is actively enrolling-- --Company assembles esteemed high quality weight loss Scientific... ► Artikel lesen | |
| CENTENE | 65,00 | -3,46 % | ROUNDUP: Centene Backs FY24 Earnings View, Lifts Revenue Forecast | WASHINGTON (dpa-AFX) - Healthcare enterprise Centene Corp. (CNC), while reporting higher second-quarter results, on Friday maintained its fiscal 2024 earnings view, but lifted revenue forecast.In... ► Artikel lesen | |
| BONESUPPORT | 25,680 | +0,86 % | Börsenpunk: Gestern Nvidia, morgen Meta? BYD mit Kaufsignal, Qualcomm fliegt, Bonesupport, ... | Das Backen ist des Börsenpunks Lust. Zumindest wenn es um die passende Aktie geht. Und die hat der Börsenpunk mit Lotus Bakeries gefunden. Gut, das Papier ist teuer, kostet über 9.000 Euro. Allerdings... ► Artikel lesen | |
| PERSPECTIVE THERAPEUTICS | 13,780 | +1,03 % | Perspective Therapeutics, Inc.: Perspective Therapeutics to Provide Business Highlights and Report Second Quarter 2024 Financial Results | ||
| LANTHEUS | 104,00 | +0,14 % | Lantheus Holdings, Inc.: Lantheus Acquires NAV-4694, a Next-Generation ß Amyloid PET Imaging Agent for Alzheimer's Disease | BEDFORD, Mass., July 15, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. ("Lantheus") (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight... ► Artikel lesen | |
| AMN HEALTHCARE SERVICES | 57,50 | +2,68 % | AMN Healthcare Services Inc. Q1 Profit Decreases, But Beats Estimates | WASHINGTON (dpa-AFX) - AMN Healthcare Services Inc. (AMN) revealed a profit for first quarter that decreased from the same period last year but beat the Street estimates.The company's bottom... ► Artikel lesen |
Das Unternehmen GENEDX HOLDINGS CORP kann der Branche Gesundheitswesen zugeordnet werden. Der aktuelle Kurs liegt bei 33,530 Euro und damit +2,48 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu GENEDX HOLDINGS CORP finden Sie auf Wallstreet Online.
